Identification of Human Leukotriene A4 Hydrolase Inhibitors Using Structure-Based Pharmacophore Modeling and Molecular Docking

Autor: Qosay Al-Balas, Amanda C. Bryant-Friedrich, Buthina A. Al-Oudat, Suaad A. Audat, Nizar A. Al-Shar’i, Mel F. Bedi, Aref Zayed
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Leukotriene B4
Pharmaceutical Science
Article
Analytical Chemistry
Leukotriene-A4 hydrolase
lcsh:QD241-441
03 medical and health sciences
chemistry.chemical_compound
Structure-Activity Relationship
0302 clinical medicine
lcsh:Organic chemistry
Catalytic Domain
Neoplasms
Drug Discovery
Humans
Physical and Theoretical Chemistry
Enzyme Inhibitors
030304 developmental biology
chemistry.chemical_classification
Epoxide Hydrolases
Inflammation
leukotriene A4 hydrolase
0303 health sciences
biology
Chemistry
moelcular docking
Organic Chemistry
Active site
Biological activity
Lipid signaling
leukotriene B4
respiratory system
anti-cancer and anti-inflammatory agents
Epoxide hydrolase activity
Molecular Docking Simulation
Enzyme
Biochemistry
Chemistry (miscellaneous)
030220 oncology & carcinogenesis
Drug Design
biology.protein
pharmacophore modeling
Molecular Medicine
lipids (amino acids
peptides
and proteins)

Pharmacophore
Zdroj: Molecules, Vol 25, Iss 2871, p 2871 (2020)
Molecules
Volume 25
Issue 12
ISSN: 1420-3049
Popis: Leukotriene B4 (LTB4) is a potent, proinflammatory lipid mediator implicated in the pathologies of an array of inflammatory diseases and cancer. The biosynthesis of LTB4 is regulated by the leukotriene A4 hydrolase (LTA4H). Compounds capable of limiting the formation of LTB4, through selective inhibition of LTA4H, are expected to provide potent anti-inflammatory and anti-cancer agents. The aim of the current study is to obtain potential LTA4H inhibitors using computer-aided drug design. A hybrid 3D structure-based pharmacophore model was generated based on the crystal structure of LTA4H in complex with bestatin. The generated pharmacophore was used in a virtual screen of the Maybridge database. The retrieved hits were extensively filtered, then docked into the active site of the enzyme. Finally, they were consensually scored to yield five hits as potential LTA4H inhibitors. Consequently, the selected hits were purchased and their biological activity assessed in vitro against the epoxide hydrolase activity of LTA4H. The results were very promising, with the most active compound showing 73.6% inhibition of the basal epoxide hydrolase activity of LTA4H. The results from this exploratory study provide valuable information for the design and development of more potent and selective inhibitors.
Databáze: OpenAIRE